Georgios Chrysos

1.4k total citations
17 papers, 241 citations indexed

About

Georgios Chrysos is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Georgios Chrysos has authored 17 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Georgios Chrysos's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and Antibiotic Use and Resistance (4 papers). Georgios Chrysos is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and Antibiotic Use and Resistance (4 papers). Georgios Chrysos collaborates with scholars based in Greece, United States and Cyprus. Georgios Chrysos's co-authors include Olympia Zarkotou, Spyros Pournaras, Athanasios Tsakris, Katerina Themeli-Digalaki, Evangelia Voulgari, Athanassios Prekates, Helen Sambatakou, Anastasia Antoniadou, Emmanouil Magiorkinis and Dimitrios Paraskevis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Georgios Chrysos

14 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgios Chrysos Greece 8 105 99 99 81 52 17 241
Daniel Pryluka Argentina 6 87 0.8× 40 0.4× 51 0.5× 63 0.8× 21 0.4× 13 185
Shih‐Ping Lin Taiwan 11 139 1.3× 129 1.3× 42 0.4× 49 0.6× 8 0.2× 26 293
Carlos Mejía-Villatoro Guatemala 6 69 0.7× 50 0.5× 64 0.6× 38 0.5× 27 0.5× 10 143
Nongodo Firmin Kaboré Burkina Faso 7 104 1.0× 75 0.8× 71 0.7× 40 0.5× 33 0.6× 31 232
Julia Abernethy United Kingdom 6 170 1.6× 104 1.1× 102 1.0× 46 0.6× 57 1.1× 7 308
Zaira R. Palacios‐Baena Spain 9 75 0.7× 65 0.7× 108 1.1× 14 0.2× 76 1.5× 28 262
Bülent Durdu Türkiye 8 64 0.6× 85 0.9× 81 0.8× 12 0.1× 35 0.7× 37 216
Zhi-Yuan Shi Taiwan 8 66 0.6× 34 0.3× 82 0.8× 7 0.1× 32 0.6× 11 230
Luis Escosa‐García Spain 8 64 0.6× 79 0.8× 86 0.9× 5 0.1× 72 1.4× 34 230
Marco Berruti Italy 7 120 1.1× 34 0.3× 28 0.3× 44 0.5× 9 0.2× 14 180

Countries citing papers authored by Georgios Chrysos

Since Specialization
Citations

This map shows the geographic impact of Georgios Chrysos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Chrysos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Chrysos more than expected).

Fields of papers citing papers by Georgios Chrysos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgios Chrysos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Chrysos. The network helps show where Georgios Chrysos may publish in the future.

Co-authorship network of co-authors of Georgios Chrysos

This figure shows the co-authorship network connecting the top 25 collaborators of Georgios Chrysos. A scholar is included among the top collaborators of Georgios Chrysos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgios Chrysos. Georgios Chrysos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kyriazopoulou, Evdoxia, Georgia Damoraki, Panagiotis Koufargyris, et al.. (2025). Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial. International Journal of Antimicrobial Agents. 66(2). 107507–107507. 1 indexed citations
2.
Basoulis, Dimitrios, Vassiliki Rapti, Maria N. Gamaletsou, et al.. (2025). Deaths “due to” COVID-19 and deaths “with” COVID-19 during the Omicron variant surge, among hospitalized patients in seven tertiary-care hospitals, Athens, Greece. Scientific Reports. 15(1). 13728–13728. 2 indexed citations
3.
Thomadakis, Christos, Dimitrios Basoulis, Οlga Tsachouridou, et al.. (2024). HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Viruses. 16(6). 885–885.
4.
5.
Pantazis, Nikos, Vasilios Papastamopoulos, Simeon Metallidis, et al.. (2023). Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART. PLoS ONE. 18(3). e0283648–e0283648. 5 indexed citations
6.
7.
Touloumi, Giota, Christos Thomadakis, Vasileios Papastamopoulos, et al.. (2022). HIV continuum of care: bridging cross-sectional and longitudinal analyses.. PubMed. 36(4). 583–591. 4 indexed citations
8.
Pantazis, Nikos, Vasilios Papastamopoulos, Anastasia Antoniadou, et al.. (2022). Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug. Viruses. 14(8). 1677–1677. 8 indexed citations
9.
Zarkotou, Olympia, et al.. (2021). Impact of a 4-year antimicrobial stewardship program implemented in a Greek tertiary hospital. European Journal of Clinical Microbiology & Infectious Diseases. 41(1). 127–132. 9 indexed citations
10.
Touloumi, Giota, Christos Thomadakis, Vasileios Papastamopoulos, et al.. (2021). HIV continuum of care: bridging cross-sectional and longitudinal analyses. AIDS. 36(4). 583–591. 6 indexed citations
11.
Pantazis, Nikos, Vasilios Papastamopoulos, Simeon Metallidis, et al.. (2019). Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy. AIDS. 33(10). 1645–1655. 16 indexed citations
12.
Vourli, Georgia, Georgios K. Nikolopoulos, Athanasios Skoutelis, et al.. (2018). HIV cascade of care in Greece: Useful insights from additional stages. PLoS ONE. 13(11). e0207355–e0207355. 12 indexed citations
13.
Chrysos, Georgios. (2017). Development of effective hospital-based antibiotic stewardship program. The role of infectious disease specialist. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Zarkotou, Olympia, et al.. (2017). First-year results of an antibiotic stewardship program in a Greek tertiary care hospital. European Journal of Clinical Microbiology & Infectious Diseases. 37(2). 333–337. 7 indexed citations
15.
Zarkotou, Olympia, Spyros Pournaras, Evangelia Voulgari, et al.. (2010). Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae : a Matched Case-Control Study. Journal of Clinical Microbiology. 48(6). 2271–2274. 87 indexed citations
16.
Paraskevis, Dimitrios, Emmanouil Magiorkinis, Gkikas Magiorkinis, et al.. (2007). Increasing Prevalence of HIV‐1 Subtype A in Greece: Estimating Epidemic History and Origin. The Journal of Infectious Diseases. 196(8). 1167–1176. 54 indexed citations
17.
Paraskevis, Dimitrios, Emmanouil Magiorkinis, Gkikas Magiorkinis, et al.. (2001). Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. Journal of General Virology. 82(10). 2509–2514. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Pryluka Breakdown of academic impact, for papers by Shih‐Ping Lin Breakdown of academic impact, for papers by Carlos Mejía-Villatoro Breakdown of academic impact, for papers by Nongodo Firmin Kaboré Breakdown of academic impact, for papers by Julia Abernethy Breakdown of academic impact, for papers by Zaira R. Palacios‐Baena Breakdown of academic impact, for papers by Bülent Durdu Breakdown of academic impact, for papers by Zhi-Yuan Shi Breakdown of academic impact, for papers by Luis Escosa‐García Breakdown of academic impact, for papers by Marco Berruti
Rankless by CCL
2026